Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Molecular cytogenetic characterization of two established ESFT cell lines.

Ishiguro M, Yuki M, Fukushige T, Mizoguchi M, Kaneko Y, Morishige T, Iwasaki H.

Hum Cell. 2017 Jan;30(1):41-48. doi: 10.1007/s13577-016-0145-7. Epub 2016 Sep 9.

PMID:
27613543
2.

Ewing's sarcoma in the spinal nerve root: a case report and review of the literature.

Isefuku S, Seki M, Tajino T, Hakozaki M, Asano S, Hojo H, Hatori M.

Tohoku J Exp Med. 2006 Aug;209(4):369-77.

3.

The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.

Vural C, Uluoğlu O, Akyürek N, Oğuz A, Karadeniz C.

Pathol Oncol Res. 2011 Sep;17(3):619-25. doi: 10.1007/s12253-010-9358-3. Epub 2011 Jan 26.

PMID:
21267687
4.

Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.

Stegmaier S, Leuschner I, Aakcha-Rudel E, Münch P, Kazanowska B, Bekassy A, Treuner J, Koscielniak E.

Klin Padiatr. 2004 Nov-Dec;216(6):315-22.

PMID:
15565546
5.

Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.

Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ.

J Natl Cancer Inst. 2011 Jun 22;103(12):962-78. doi: 10.1093/jnci/djr156. Epub 2011 Jun 8.

6.

Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.

Tirado OM, Mateo-Lozano S, Villar J, Dettin LE, Llort A, Gallego S, Ban J, Kovar H, Notario V.

Cancer Res. 2006 Oct 15;66(20):9937-47.

7.

Diagnostic significance and clinical applications of chimeric genes in Ewing's sarcoma.

Yoshino N, Kojima T, Asami S, Motohashi S, Yoshida Y, Chin M, Shichino H, Yoshida Y, Nemoto N, Kaneko M, Mugishima H, Suzuki T.

Biol Pharm Bull. 2003 May;26(5):585-8.

8.

A molecular function map of Ewing's sarcoma.

Kauer M, Ban J, Kofler R, Walker B, Davis S, Meltzer P, Kovar H.

PLoS One. 2009;4(4):e5415. doi: 10.1371/journal.pone.0005415. Epub 2009 Apr 30.

9.

Esophageal extraskeletal Ewing's sarcoma.

Maesawa C, Iijima S, Sato N, Yoshinori N, Suzuki M, Tarusawa M, Ishida K, Tamura G, Saito K, Masuda T.

Hum Pathol. 2002 Jan;33(1):130-2.

PMID:
11823984
10.

A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.

Leacock SW, Basse AN, Chandler GL, Kirk AM, Rakheja D, Amatruda JF.

Dis Model Mech. 2012 Jan;5(1):95-106. doi: 10.1242/dmm.007401. Epub 2011 Oct 6.

11.

Ewing sarcoma family of tumors.

Khoury JD.

Adv Anat Pathol. 2005 Jul;12(4):212-20. Review.

PMID:
16096383
12.

Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction.

Downing JR, Head DR, Parham DM, Douglass EC, Hulshof MG, Link MP, Motroni TA, Grier HE, Curcio-Brint AM, Shapiro DN.

Am J Pathol. 1993 Nov;143(5):1294-300.

13.

Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.

Machado I, Navarro L, Pellin A, Navarro S, Agaimy A, Tardío JC, Karseladze A, Petrov S, Scotlandi K, Picci P, Llombart-Bosch A.

Ann Diagn Pathol. 2016 Jun;22:25-32. doi: 10.1016/j.anndiagpath.2016.03.002. Epub 2016 Mar 14.

PMID:
27180056
14.

Renal primitive neuroectodermal tumor: a morphologic, cytogenetic, and molecular analysis with the establishment of two cultured cell lines.

Takeuchi T, Iwasaki H, Ohjimi Y, Ohshima K, Kaneko Y, Ishiguro M, Hiratsuka Y, Sakamoto K, Kikuchi M.

Diagn Mol Pathol. 1997 Dec;6(6):309-17.

PMID:
9559290
15.

Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.

Rekhi B, Vogel U, Basak R, Desai SB, Jambhekar NA.

Pathol Oncol Res. 2014 Jul;20(3):503-16. doi: 10.1007/s12253-013-9721-2. Epub 2013 Nov 30.

PMID:
24293381
16.

EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.

Ban J, Siligan C, Kreppel M, Aryee D, Kovar H.

Adv Exp Med Biol. 2006;587:41-52. Review.

PMID:
17163154
17.

Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.

Folpe AL, Goldblum JR, Rubin BP, Shehata BM, Liu W, Dei Tos AP, Weiss SW.

Am J Surg Pathol. 2005 Aug;29(8):1025-33.

PMID:
16006796
18.

Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.

Jimenez RE, Folpe AL, Lapham RL, Ro JY, O'Shea PA, Weiss SW, Amin MB.

Am J Surg Pathol. 2002 Mar;26(3):320-7.

PMID:
11859203
19.

Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.

Savola S, Klami A, Tripathi A, Niini T, Serra M, Picci P, Kaski S, Zambelli D, Scotlandi K, Knuutila S.

BMC Cancer. 2009 Jan 14;9:17. doi: 10.1186/1471-2407-9-17.

20.

Primary Ewing sarcoma of the stomach--a newly described entity.

Rafailidis S, Ballas K, Psarras K, Pavlidis T, Symeonidis N, Marakis G, Sakadamis A.

Eur Surg Res. 2009;42(1):17-20. doi: 10.1159/000166166. Epub 2008 Oct 30.

PMID:
18971581

Supplemental Content

Support Center